406 related articles for article (PubMed ID: 6781527)
1. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
Mannucci PM; Canciani MT; Rota L; Donovan BS
Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
[TBL] [Abstract][Full Text] [Related]
2. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
[TBL] [Abstract][Full Text] [Related]
3. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
4. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
5. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).
Mannucci PM; Bettega D; Cattaneo M
Br J Haematol; 1992 Sep; 82(1):87-93. PubMed ID: 1419807
[TBL] [Abstract][Full Text] [Related]
6. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
Warrier AI; Lusher JM
J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
[TBL] [Abstract][Full Text] [Related]
7. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
Niessner H; Korninger C
Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
[TBL] [Abstract][Full Text] [Related]
8. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
[TBL] [Abstract][Full Text] [Related]
9. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
10. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
Greer IA; McLaren M; Belch JJ; Lowe GD; Forbes CD
Haemostasis; 1986; 16(1):15-9. PubMed ID: 3084364
[TBL] [Abstract][Full Text] [Related]
11. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
[TBL] [Abstract][Full Text] [Related]
12. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
Moffat EH; Giddings JC; Bloom AL
Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J
Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
16. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
Garcia VV; Silva IA; Borrasca AL
Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999
[TBL] [Abstract][Full Text] [Related]
17. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's.
Marwick C
JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692
[No Abstract] [Full Text] [Related]
18. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
Johnstone IB; Crane S
Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
[TBL] [Abstract][Full Text] [Related]
19. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
[No Abstract] [Full Text] [Related]
20. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
